Exchanges NYSE


  • "Dow 10,000 Again" hat

    Stocks opened lower on Thursday after the Dow closed above 10,000 on Wednesday for the first time since last October. Art Cashin, director of floor operations at UBS Financial Services, said the 10,000 number is not that significant and offered his market outlook.

  • New Rivals Pose Threat to New York Stock Exchange Thursday, 15 Oct 2009 | 10:18 AM ET

    Even as the Dow Jones industrial average topped 10,000 for the first time since the financial crisis sent it tumbling, the NYSE and its hometown face an unsettling truth: the Big Board , the symbolic heart of New York’s financial industry, is getting smaller.

  • Top Private Equity Firm Sees Heavy Options Upside Thursday, 15 Oct 2009 | 7:44 AM ET

    Blackstone Group, one of the world's largest private equity firms, hit a 52-week high for the third straight session yesterday along with heavy upside options trading.

  • Sector Strategies for the Dow 10,000 Market Wednesday, 14 Oct 2009 | 6:08 PM ET

    Stocks rallied on Wednesday and the Dow closed above10,000 for the first time in over a year. Rick Bensignor, chief market strategist at Execution and Jill Evans, co-portfolio manager at Alpine Funds, discussed what lies ahead.

  • Art Cashin: What Dow 10,000 Really Means Wednesday, 14 Oct 2009 | 4:58 PM ET

    The Dow topped 10,000 on Wednesday, but Art Cashin, head of floor operations at UBS, said he'll continue to approach the market with caution.

  • Dow at 11,000 to 11,500 by Christmas Wednesday, 14 Oct 2009 | 4:29 PM ET

    The Federal Reserve agreed to slow down the pace of a $1.25 trillion program to buy mortgage securities, according to minutes from the FOMC meeting. Clem Chambers, CEO of ADVFN and Charles Crane, managing director at Douglass Winthrop Advisors discussed their views on the minutes of the Fed meeting.

  • 10 Stock Picks from 2 Top Investment Strategists Wednesday, 14 Oct 2009 | 4:15 PM ET

    Financials are leading stocks higher as the Dow marches toward the critical 10,000 milestone. So how high can we go this year? Dan Genter, president, CEO and CIO of RNC Genter Capital Management and Dan Fitzpatrick, president at Stockmarket Mentor, discussed their market outlooks.

  • Byron Wien's 2009 Market Predictions: Was He Right? Wednesday, 14 Oct 2009 | 3:55 PM ET

    Legendary Wall Street investor Byron Wien, senior managing director at Blackstone Group, issued his predictions of top surprises for 2009 at the beginning of the year. Ten months later, he discussed those predictions with CNBC.

  • My Intel Price Target Now: Tech Analyst Wednesday, 14 Oct 2009 | 1:26 PM ET

    Intel’s quarterly outlook and results shattered expectations on Tuesday afternoon, boosting its shares to a 52-week high and fueling optimism over a tech sector recovery before the crucial holiday season. Craig Berger, senior technology, media and telecom analyst with FBR Capital Markets shared his insights on the microprocessor giant.

  • Art Cashin: How Today's Market Is Like Dot-Com Bubble Wednesday, 14 Oct 2009 | 12:32 PM ET

    The stock rally could have legs after a line of better-than-expected third-quarter earnings reports, but Art Cashin, head of floor operations at UBS, said he isn't yet convinced.

  • Use VIX to Protect Your Portfolio: Strategist Wednesday, 14 Oct 2009 | 11:38 AM ET

    The CBOE Volatility index (VIX), widely considered the best gauge of fear in the market, is currently trading below 23, well off its high near 80 last fall. How can investors use the VIX to benefit their portfolios? Paul Britton, CEO and founder of Capstone, shared his volatility strategy.

  • Why JPMorgan Peers Look Good Now: Equity Pro Wednesday, 14 Oct 2009 | 10:42 AM ET

    JPMorgan Chase reported sharply higher third-quarter results that blew past Wall Street expectations. Jeffery Harte, managing director of equity research at Sandler O’Neill, shared his analysis of the financial giant.

  • Gold, Oil and Cash: 2 Investment Advisors' Strategies Wednesday, 14 Oct 2009 | 10:01 AM ET

    Should investors stick with equities or hold onto their cash instead? James Moffett, chairman of Scout Investment Advisors, and Charles de Vaulx, portfolio manager at IVA Funds, shared their best investment strategies.

  • More Volatility Ahead for This Chip Firm: Options Trader Wednesday, 14 Oct 2009 | 7:47 AM ET

    RF Micro Devices has seen a lot of volatility over the last few years, and one trader sees more of it in the next few days for the semiconductor company.

  • earnings_central_badge.jpg

    Railroad company CSX releases its third-quarter earnings Tuesday, but Donald Broughton, transportation analyst at Avondale Partners, said he wouldn't buy into the company at its current levels because of lower volumes and pricing risks associated with railroads.

  • Stocks or commodities? David Chalupnik, head of equities at First American Funds, told investors where they should be looking.

  • The Next Banks to Struggle: Camden Fine Tuesday, 13 Oct 2009 | 3:09 PM ET

    Camden Fine, CEO of the Independent Community Bankers of America, said the 1,200 to 1,500 community banks that deal directly with agriculture could be the next to struggle, due to inflated commodities and farmland prices.

  • Dow at 11,000 by Year End: Portfolio Manager Tuesday, 13 Oct 2009 | 1:37 PM ET

    Investors are keeping their eyes on earnings and Dow 10,000—so what does it mean for your portfolio and how should you be positioning yourself right now? Jim Lacamp, portfolio manager and advisor at Macroportfolio Advisors and Craig Peckham, equity trading strategist at Jefferies & Co. weighed in.

  • Top Fund Manager’s 4 Winning Dow Stocks Tuesday, 13 Oct 2009 | 1:10 PM ET

    Tom Forester, portfolio manager of the 5-star Morningstar rated Forester Value Fund, shared his investment strategy and stock picks.

  • JNJ Facing a 'Tough Period': Medical Tech Analyst Tuesday, 13 Oct 2009 | 11:56 AM ET

    Dow component Johnson & Johnson—the first major health care company to report earnings this quarter—posted weaker-than-expected quarterly revenue on Tuesday. Mike Weinstein, managing director and senior medical technology analyst at JPMorgan, offered his analysis of JNJ.